A Study for Assessing the Efficacy and Safety of Tetrahydrobiopterin in Radiation-Induced Skin Injury

NCT05114226 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Radiation-Induced Dermatitis

Interventions

DRUG: Tetrahydrobiopterin

Sponsor

West China Second University Hospital